Screening for Biomarkers of Osteonecrosis of the Femoral Head
Recruiting
Observational Study
Osteonecrosis of the Femoral Head
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 70
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- The First Affiliated Hospital of Xinxiang Medical College · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Osteonecrosis of the femoral head (ONFH) presents a rapidly progressive natural disease course. Femoral head collapse may occur within two years, ultimately necessitating total hip arthroplasty and imposing a heavy medical and economic burden on patients. Early intervention can significantly improve the long-term prognosis of ONFH. However, due to the lack of validated biomarkers for early diagnos…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Aged between 18 and 70 years old (inclusive).
2. Patients with suspected ONFH.
3. Those who provide informed consent and volunteer to participate in this study.
Exclusion Criteria:
1. Patients with a clear history of hip trauma.
2. Patients with ONFH secondary to traumatic …
Contacts